Wells Fargo’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-430
Closed -$1.93K 7804
2023
Q4
$1.93K Hold
430
﹤0.01% 6109
2023
Q3
$2.58K Hold
430
﹤0.01% 6055
2023
Q2
$5.27K Buy
430
+400
+1,333% +$5.11K ﹤0.01% 6072
2023
Q1
$426 Hold
30
﹤0.01% 6595
2022
Q4
$446 Hold
30
﹤0.01% 6417
2022
Q3
$1K Buy
30
+1
+3% +$57 ﹤0.01% 6521
2022
Q2
$2K Sell
29
-563
-95% -$49.4K ﹤0.01% 6413
2022
Q1
$28K Buy
592
+427
+259% +$25.7K ﹤0.01% 5896
2021
Q4
$12K Sell
165
-462
-74% -$49.8K ﹤0.01% 6491
2021
Q3
$92K Buy
627
+601
+2,312% +$182K ﹤0.01% 5423
2021
Q2
$16K Hold
26
﹤0.01% 5992
2021
Q1
$18K Buy
+26
New +$18.7K ﹤0.01% 6192
2020
Q4
Hold
0
7202
2020
Q3
Hold
0
7095
2020
Q2
Hold
0
6998
2020
Q1
Hold
0
6998

Wells Fargo's MDVL Position: Q1 2024 in Review

Wells Fargo sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 430 shares — an estimated $1.93K sold.

Wells Fargo first reported a position in MDVL in Q1 2021 and held it in 12 quarters. The position peaked at $92K in Q3 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.

  • Wells Fargo reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 430 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $1.93K.
  • Wells Fargo first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Wells Fargo's MedAvail Holdings, Inc. Common Stock position peaked at $92K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.